Neil Abdollahian
2018
In 2018, Neil Abdollahian earned a total compensation of $640.1K as Chief Business Officer at Cidara Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $100,400 |
|---|---|
| Option Awards | $196,994 |
| Salary | $340,000 |
| Other | $2,750 |
| Total | $640,144 |
Abdollahian received $340K in salary, accounting for 53% of the total pay in 2018.
Abdollahian also received $100.4K in non-equity incentive plan, $197K in option awards and $2.8K in other compensation.
Rankings
In 2018, Neil Abdollahian's compensation ranked 11,040th out of 14,244 executives tracked by ExecPay. In other words, Abdollahian earned more than 22.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,040 out of 14,244 | 23rd |
Division Manufacturing | 4,449 out of 5,765 | 23rd |
Major group Chemicals And Allied Products | 1,688 out of 2,128 | 21st |
Industry group Drugs | 1,432 out of 1,817 | 21st |
Industry Biological Products, Except Diagnostic Substances | 276 out of 339 | 19th |
Source: SEC filing on April 29, 2020.
Abdollahian's colleagues
We found three more compensation records of executives who worked with Neil Abdollahian at Cidara Therapeutics in 2018.